StockDuty
Jun 07, 2026 04:15 AM ET
Signal
Earnings
$APLS — Develops therapies for rare, life-threatening diseases.
What changed
$APLS — Develops therapies for rare, life-threatening diseases. Q1: - Revenue: $268M - Adj EPS: $0.15 vs $-0.36 - Adj operating margin: 9.9% (📈 +59.8pp YoY)
Why it matters
Q1:
Sources
pipeline
Related signals
🚨 100% of S&P 500 market cap has now reported Q1 2026. →
📊 S&P 500 Q2 2026 Earnings Update — Mid-season →
$AMAT — AVOID 📊 | 6 MONTHS THESIS →